De-risking primary prevention: role of imaging

Atherosclerotic cardiovascular disease (ASCVD) is a common disease among the general population, and includes four major areas: (1) coronary heart disease (CHD), manifested by stable angina, unstable angina, myocardial infarction (MI), heart failure, and coronary death; (2) cerebrovascular disease,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmed M. Shafter, Kashif Shaikh, Amit Johanis, Matthew J. Budoff
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/bc2d7630e264405c875ee99db8d9d28c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc2d7630e264405c875ee99db8d9d28c
record_format dspace
spelling oai:doaj.org-article:bc2d7630e264405c875ee99db8d9d28c2021-12-01T00:06:15ZDe-risking primary prevention: role of imaging1753-945510.1177/17539447211051248https://doaj.org/article/bc2d7630e264405c875ee99db8d9d28c2021-11-01T00:00:00Zhttps://doi.org/10.1177/17539447211051248https://doaj.org/toc/1753-9455Atherosclerotic cardiovascular disease (ASCVD) is a common disease among the general population, and includes four major areas: (1) coronary heart disease (CHD), manifested by stable angina, unstable angina, myocardial infarction (MI), heart failure, and coronary death; (2) cerebrovascular disease, manifested by transient ischemia attack and stroke; (3) peripheral vascular disease, manifested by claudication and critical limb ischemia; and (4) aortic atherosclerosis and aortic aneurysm (thoracic and abdominal). CHD remains the leading cause of death for both men and women in the United States. So, it is imperative to identify people at risk of CHD and provide appropriate medical treatment or intervention to prevent serious complications and outcomes including sudden cardiac death. Coronary artery calcification (CAC) is a marker of subclinical coronary artery disease. Therefore, coronary artery calcium score is an important screening method for Coronary artery disease (CAD). In this article, we performed a comprehensive review of current literatures and studies assessing the prognostic value of CAC for future cardiovascular disease (CVD) events. We searched PubMed, MEDLINE, Google Scholar, and Cochrane library. We also reviewed the 2018 American College of Cardiology (ACC)/American Heart Association (AHA) guideline on the assessment of CVD risk. A CAC score of zero corresponds to very low CVD event rates (∼1% per year) and hence a potent negative risk marker. This has been referred to as the ‘power of zero’ and affords the lowest risk of any method of risk calculation. It is now indicated in the 2018 ACC/AHA Cholesterol guidelines to be used to avoid statins for 5–10 years after a score of zero, and then re-assess the patient.Ahmed M. ShafterKashif ShaikhAmit JohanisMatthew J. BudoffSAGE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENTherapeutic Advances in Cardiovascular Disease, Vol 15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Ahmed M. Shafter
Kashif Shaikh
Amit Johanis
Matthew J. Budoff
De-risking primary prevention: role of imaging
description Atherosclerotic cardiovascular disease (ASCVD) is a common disease among the general population, and includes four major areas: (1) coronary heart disease (CHD), manifested by stable angina, unstable angina, myocardial infarction (MI), heart failure, and coronary death; (2) cerebrovascular disease, manifested by transient ischemia attack and stroke; (3) peripheral vascular disease, manifested by claudication and critical limb ischemia; and (4) aortic atherosclerosis and aortic aneurysm (thoracic and abdominal). CHD remains the leading cause of death for both men and women in the United States. So, it is imperative to identify people at risk of CHD and provide appropriate medical treatment or intervention to prevent serious complications and outcomes including sudden cardiac death. Coronary artery calcification (CAC) is a marker of subclinical coronary artery disease. Therefore, coronary artery calcium score is an important screening method for Coronary artery disease (CAD). In this article, we performed a comprehensive review of current literatures and studies assessing the prognostic value of CAC for future cardiovascular disease (CVD) events. We searched PubMed, MEDLINE, Google Scholar, and Cochrane library. We also reviewed the 2018 American College of Cardiology (ACC)/American Heart Association (AHA) guideline on the assessment of CVD risk. A CAC score of zero corresponds to very low CVD event rates (∼1% per year) and hence a potent negative risk marker. This has been referred to as the ‘power of zero’ and affords the lowest risk of any method of risk calculation. It is now indicated in the 2018 ACC/AHA Cholesterol guidelines to be used to avoid statins for 5–10 years after a score of zero, and then re-assess the patient.
format article
author Ahmed M. Shafter
Kashif Shaikh
Amit Johanis
Matthew J. Budoff
author_facet Ahmed M. Shafter
Kashif Shaikh
Amit Johanis
Matthew J. Budoff
author_sort Ahmed M. Shafter
title De-risking primary prevention: role of imaging
title_short De-risking primary prevention: role of imaging
title_full De-risking primary prevention: role of imaging
title_fullStr De-risking primary prevention: role of imaging
title_full_unstemmed De-risking primary prevention: role of imaging
title_sort de-risking primary prevention: role of imaging
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/bc2d7630e264405c875ee99db8d9d28c
work_keys_str_mv AT ahmedmshafter deriskingprimarypreventionroleofimaging
AT kashifshaikh deriskingprimarypreventionroleofimaging
AT amitjohanis deriskingprimarypreventionroleofimaging
AT matthewjbudoff deriskingprimarypreventionroleofimaging
_version_ 1718406161562075136